Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Lines”

150 trials

Showing 20 of 150 results

Very early researchStudy completedNCT05129319
What this trial is testing

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 30
Not applicableStudy completedNCT02043145
What this trial is testing

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

Who this might be right for
HyperhidrosisMuscle SpasticityGlabellar Lines
Allergan 727
Post-approval studies (Phase 4)Study completedNCT00856414
What this trial is testing

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Skin Aging
Allergan 45
Testing effectiveness (Phase 2)Study completedNCT06199336
What this trial is testing

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 190
Early research (Phase 1)Study completedNCT06604832
What this trial is testing

Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

Who this might be right for
Skin AgingSkin Wrinkling
Kalpna Kay Durairaj, MD, FACS 20
Large-scale testing (Phase 3)Study completedNCT03732833
What this trial is testing

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Who this might be right for
Lateral Canthal LinesGlabellar Lines
Medy-Tox 425
Testing effectiveness (Phase 2)Active Not RecruitingNCT07321834
What this trial is testing

Evaluate AI-09 In Participants With Glabellar Lines

Who this might be right for
Glabellar Lines
Eirion Therapeutics Inc. 68
Testing effectiveness (Phase 2)Study completedNCT04763265
What this trial is testing

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

Who this might be right for
Frown Lines
Croma-Pharma GmbH 208
Not applicableEnded earlyNCT05222607
What this trial is testing

Longitudinal Evaluation and Real-world Evidence of NT201

Who this might be right for
Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face
Merz North America, Inc. 11
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Looking for participantsNCT06205797
What this trial is testing

To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

Who this might be right for
Glabellar Lines
Huons Biopharma 312
Not applicableWithdrawnNCT05894109
What this trial is testing

Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids

Who this might be right for
Adjuvant Zinc May Increase the Efficacy of Botulinum ToxinZinc Supplementation for Botulinum Toxin Treatment of the ForeheadGlabellar Frown Lines+2 more
University of New Mexico
Large-scale testing (Phase 3)Study completedNCT05148000
What this trial is testing

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Who this might be right for
Glabellar Frown LinesCanthal Lines
Galderma R&D 25
Large-scale testing (Phase 3)Study completedNCT04830345
What this trial is testing

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
EuBiologics Co.,Ltd 290
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT05321979
What this trial is testing

Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 253
Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381
Large-scale testing (Phase 3)Study completedNCT03837561
What this trial is testing

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 136
Early research (Phase 1)Study completedNCT06212960
What this trial is testing

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation